Acetylsalicylic acid Completed Phase 4 Trials for Peripheral Arterial Disease (PAD) Health Services Research

IndicationsStatusPurposePhase
CompletedHealth Services Research4
clinicaltrials.gov IdentifierTitleDrugs
NCT00687076Effectiveness of Intensive Lipid Modification Medication in Preventing the Progression of Peripheral Arterial Disease (The ELIMIT Study)